===============================================================================
SECURITIES AND EXCHANGE COMMISSION
Washington D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
January 31, 1997
Medical Technology & Innovations, Inc.
(Exact name of registrant as specified in this charter)
Florida 33-27610-A 59-2954561
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification Number)
3125 Nolt Road, Lancaster, PA 17601
(Address of principal executive offices)
Registrant's telephone number, including area code (717) 892-6770
================================================================================
Item 1. Changes in Control of Registrant
Not Applicable
Item 2. Acquisition or Disposition of Assets
Not Applicable
Item 3. Bankruptcy or Receivership
Not Applicable
Item 4. Changes in Registrant's Certifying Accountant
Not Applicable
Item 5. Other Events
Not Applicable
Item 6. Resignation of Registrant's Directors
On or about January 31, 1997 the Company received a letter of resignation from
Thomas Penaluna. Mr. Penaluna had no disagreement with the registrant on any
matter relating to the registrant's operations, policies, or practices. Mr. Penaluna
resigned to more actively pursue other business interests.
Item 7. Financial Statements and Exhibits
(c) Exhibits
17.1 Director Resignation Letter
Item 8. Change in Fiscal Year
Not Applicable
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Date: February 10, 1997
Medical Technology & Innovations, Inc.
(Registrant)
By: /s/ JEREMY FEAKINS
----------------------------------------
Jeremy Feakins, Chief Executive Officer